MONDAY, Oct. 28, 2024 (HealthDay News) — The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide — the active agent in Ozempic and Wegovy — had as much as a 52% reduction in kidney damage, as measured by urine testing,Continue Reading
WEDNESDAY, Oct. 23, 2024 (HealthDay News) — Type 2 diabetes is caused in part by the failure of pancreatic beta cells to respond as they should to blood sugar. Now, new research suggests that switching to a low-carbohydrate diet might correct that beta cell dysfunction, boosting patients’ health. “People withContinue Reading
THURSDAY, Oct. 17, 2024 (HealthDay News) — A new, reassuring study finds that men can take the diabetes drug metformin without worrying that their offspring will suffer from birth defects. Recent research raised concerns that metformin could promote birth defects in children by damaging the quality of a man’s sperm.Continue Reading
MONDAY, Oct. 14, 2024 (HealthDay News) — Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with type 2 diabetes. The new trial hasn’t yet been published in aContinue Reading
MONDAY, Oct. 7, 2024 (HealthDay News) — Two new studies show insurers continue to deny claims for preventive care that is supposed to be free under Obamacare. And insurers are more apt to reject claims from patients who are Asian, Black or Hispanic as well as those with low incomes,Continue Reading
-690x550.jpg)
THURSDAY, Sept. 26, 2024 (HealthDay News) — There’s good news for folks who struggle to fit regular exercise into their busy workweek. “Weekend warrior” workouts are just as beneficial as daily exercise to a person’s overall health, a new study says. People who get all their weekly recommended exercise inContinue Reading
TUESDAY, Sept. 24, 2024 (HealthDay News) — If a woman is already in a “prediabetic” state in her teen or college years, her odds for a serious complication of pregnancy later in life rises, new research shows. Ignoring prediabetes in teenagers “may represent a missed opportunity to avert pregnancy-related complications”Continue Reading
TUESDAY, Sept. 24, 2024 (HealthDay News) — Over 40 percent of U.S. adults are now obese, with rates roughly the same for men and women, new government data shows. Obesity rates fluctuated with age and fell as levels of education increased, said the report from the U.S. Centers for DiseaseContinue Reading
MONDAY, Sept. 23, 2024 (HealthDay News) — Diabetes can worsen the state of your gums, but a new study suggests that diabetes medications may undo some of that damage. Researchers in Japan found a positive turnaround in markers of gum well-being after people with diabetes received medication. “Promoting collaboration betweenContinue Reading
THURSDAY, Sept. 19, 2024 (HealthDay News) — One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users’ odds for Long COVID. Long COVID can present with symptoms including chronic fatigue, brain fog and chest pain and it may last weeks or months after an initial COVIDContinue Reading
THURSDAY, Sept. 19, 2024 (HealthDay News) — A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream andContinue Reading
TUESDAY, Sept. 17, 2024 (HealthDay News) — A few cups of coffee each morning can help protect a person against heart disease, stroke and type 2 diabetes, a new study says. Drinking three cups of coffee a day — or about 200 to 300 milligrams of caffeine — lowered theContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, veterans with diabetes and what’s known as metabolic dysfunction-associated steatotic liverContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Overweight or obese type 1 diabetics taking Mounjaro were able to reduce theContinue Reading